Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
Switch Symbol:
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
5.82
↓ 90% below average
Average (9y)
57.09
Historical baseline
Range
High:241.79
Low:5.82
CAGR
-33.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 5.82 | -14.7% |
| 2023 | 6.82 | -11.2% |
| 2022 | 7.69 | +8.1% |
| 2021 | 7.11 | -16.7% |
| 2020 | 8.53 | -31.7% |
| 2019 | 12.50 | -17.2% |
| 2018 | 15.10 | -64.3% |
| 2017 | 42.24 | -81.1% |
| 2016 | 223.32 | -7.6% |
| 2015 | 241.79 | - |